{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-030659","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2023-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.798139+00:00","generated_at":"2026-06-11T01:52:42.058561+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Daré Bioscience raises $7.0M in registered direct offering of 10M shares and warrants","bullets":["Total gross proceeds of $7.0M from sale of 10M shares and warrants at $0.70/unit.","Warrants exercisable after 6 months at $0.77/share for 5.5 years, with 4.99% ownership limitation.","Investors include an institutional investor and an affiliate of the licensor of an early stage product candidate.","Closing expected September 1, 2023; proceeds for general corporate purposes, including clinical trials and R&D.","Offered under existing S-3 shelf registration statement; prospectus supplement to be filed with SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-030659","json":"https://secwatch.observer/filing/0001493152-23-030659.json","markdown":"https://secwatch.observer/filing/0001493152-23-030659.md","text":"https://secwatch.observer/filing/0001493152-23-030659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223030659/0001493152-23-030659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223030659/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T01:52:42.058561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9f29a87752e24586c52dfb32fd00cefd4b6b758e","claim":"Dare Bioscience, Inc. entered into securities purchase agreement with two institutional investors valued at aggregate gross proceeds to Daré from the offering are expected to be $7.0 million (effective 2023-08-29).","evidence_excerpt":"On August 29, 2023, Daré Bioscience, Inc. (the “Company” or “Daré”) entered into a securities purchase agreement with two institutional investors relating to the purchase and sale in a registered direct offering of an aggregate of (i) 10,000,000 shares of Daré’s common stock, and (ii) warrants to purchase an aggregate of 10,000,000 shares of Daré’s common stock.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401914/000149315223030659/0001493152-23-030659-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"two institutional investors"},{"label":"Value","value":"aggregate gross proceeds to Daré from the offering are expected to be $7.0 million"},{"label":"Effective","value":"2023-08-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}